Avella Specialty Pharmacy acquires Oncology Plus
PHOENIX, Ariz. — On the heels of its announcement that it had hired a new medical advisor, Avella Specialty Pharmacy on Monday announced that it had acquired Oncology Plus, a Tampa, Fla.-based provider of patient-specific compounded therapies. Avella said that the acquisition would further its strategic vision to become the nation’s leading omni-site specialty pharmacy and add breadth to its compounding and oncology-focused capabilities and offerings.
“Oncology Plus is dedicated to providing unsurpassed value to its customers while ensuring the highest levels of quality and safety,” Avella CEO Rebecca Shanahan said. “This aligns perfectly with Avella's own high standards for our business. As a result, the move to integrate the people and products of Oncology Plus within our own compounding capabilities will give us greater scale and unique capabilities to service all of the pharmacy outsourcing needs of our practice and hospital partners."
With the acquisition, Avella adds Oncology Plus’s 5,000-sq. ft. facility and its Logics+ proprietary ordering, dosing and pathway compliance software. The company said its oncology offerings now span across such sites of care as the physician’s office, retail pharmacies and hospitals, and it expands its offerings to include compounded and oral therapies. Avella also serves hospitals and health systems through its 340B drug discount program, and it has recently announced the acquisition of Texas-based Advanced Pharma.
"We are very excited to become part of a specialty pharmacy with such a strong reputation for clinical excellence and high-quality compounding," said Zach Scholl, President of Oncology Plus. "Avella's national footprint, industry relationships and expertise in the oncology space, combined with the IV compounding capabilities of Oncology Plus, will uniquely position us as a leader in this marketplace."
Oncology Plus will be rebranded as part of Avella.
Avella Specialty Pharmacy adds medical advisor
PHOENIX, Ariz. — Avella Specialty Pharmacy has added Dr. Joel V. Brill as a medical advisor, the organization announced Friday. Brill will bring more than 30 years of clinical and leadership experience, as well as expertise in value-based care and advanced payment models to the company.
“Specialty pharmacy is an important segment of health care, especially as organizations look for new ways to improve quality, demonstrate value, and provide cost-effective care,” Brill said. “Avella is known for its strong foundation of clinical excellence and emphasis on quality improvement and patient-focused care, which is essential for payer and provider organizations seeking to deliver value-based collaborative care that meets today’s and tomorrow’s challenges.”
Brill is board-certified in gastroenterology and internal medicine and is Predictive Health’s chief medical officer. He has formerly served as a medical director for several managed care organizations and has run independent practice organizations and physician-hospital organizations. Brill is also skilled in implementing value-driven health programs, the company said.
At Avella, he will provide insight into developing its newest clinical programs and maintaining the evidence-based care practices within the company’s specialties. He will also serve as the “voice of the provider” as Avella enters new clinical specialties and looks to partner with health systems, hospitals, physicians and payers.
“Specialty pharmacies have become such a critical part of a patient’s care team, which makes clinical leadership in our organization just as important as it would be within a hospital or health system,” Avella CEO Rebecca Shanahan said. “Dr. Brill’s extensive knowledge and understanding of the complex healthcare landscape will be invaluable as we develop cutting-edge clinical programs as well as long-term strategic partnerships.”
Loading Post Please Wait...